tk88 bet

New vaccines to be added to expanded programme on immunisation

Many new kinds of vaccines will be included in the national expanded programme on immunisation (EPI) in the coming time, said Dr. Dang Thanh Huyen, deputy head of the EPI Office under the Ministry of Health, on July 10.
New vaccines to be added to expanded programme on immunisation ảnh 1the vaccine against Rotavirus will be provided in a number of localities in 2023 and the whole nation in 2024. (Photo: nld.vom.vn)
Hanoi (VNA)– Many new kinds of vaccines will be included in the national expandedprogramme on immunisation (EPI) in the coming time, said Dr. Dang Thanh Huyen,deputy head of the EPI Office under the Ministry of Health, on July 10.

Huyen said thataccording to the roadmap, the vaccine against Rotavirus will be provided in anumber of localities in 2023 and the whole nation in 2024.

Meanwhile, vaccinesagainst pneumococcal disease, cervical cancer, and seasonal flu will beintroduced from 2025, 2026 and 2030, respectively, said the official.

New vaccines to be added to expanded programme on immunisation ảnh 2Dr. Dang Thanh Huyen, deputy head of the EPI Office under the Ministry of Health (Photo: laodong.vn)
Associate Prof. LeViet Dung, Vice Director of the Drug Administration of Vietnam, said theadministration has received registration from several units to provide vaccinesagainst the hand-foot-mouth disease. The vaccines have been classified as prioritised for consideration to grant circulation permit.

The EPI of Vietnam,which was launched in 1981, is providing immunisation to 12 vaccine preventablediseases of Tuberculosis, Hepatitis B, Diphtheria, Pertussis, Tetanus, Polio,Hib, Measles, Rubella, Japanese Encephalitis, Cholera (in high-risk areas), andTyphoid (in high-risk areas).

According to theWorld Health Organisation (WHO), in Vietnam, it is estimated that EPI has saved42,000 lives and prevented more than 6.7 million childhood diseases like polio,tetanus, diphtheria, measles and pertussis with high vaccine coverage. Official2017 data indicated a coverage of 97% for Bacille Calmette-Guérin (BCG), 97%for measles-containing vaccine (MCV) first dose, and 93% for MCV second dose./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

💫 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ꦅ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♔ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|